Reported Allergic Reactions to the Pfizer-BioNTech COVID-19 Vaccine will be part of the US Food and Drug Administration’s (FDA) considerations during the review, said Wednesday a an official with the United States Department of Health and Human Services (HHS), according to Reuters. .
The official further noted that Pfizer’s vaccine could receive an emergency use approval within days of the FDA meeting and said vaccines could begin next week.
“Regulatory standards for emergency use of COVID-19 vaccines are very close to the standards needed for full approval,” the official added, noting that full approval could come after about four months or more.
Market reaction
Market sentiment remains sour on Wednesday and the S&P 500 Index was last seen gaining 1.1% on the day at 3,660.
.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
